Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alzamend Neuro ( (ALZN) ) has provided an update.
Between September 17 and September 25, 2025, Alzamend Neuro, Inc. issued 300,000 shares of common stock following the conversion of 696 shares of Series B Convertible Preferred Stock. This issuance increased the company’s total outstanding common stock to 3,439,861 shares, reflecting a strategic financial maneuver to enhance liquidity or capital structure.
The most recent analyst rating on (ALZN) stock is a Hold with a $6.90 price target. To see the full list of analyst forecasts on Alzamend Neuro stock, see the ALZN Stock Forecast page.
More about Alzamend Neuro
Average Trading Volume: 155,946
Technical Sentiment Signal: Sell
Current Market Cap: $7.47M
For detailed information about ALZN stock, go to TipRanks’ Stock Analysis page.